New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 19, 2012
16:33 EDTEBAY, TUMI, TRV, GILD, GSK, SPLK, VZ, GNTX, HGSI, DD, BACOn The Fly: Closing Wrap
Stocks on Wall Street were lower, as disappointing economic data overshadowed earnings that were largely better than expected. Stock futures were higher in early trading but weakened following disappointing jobless claims data and a rumor the sovereign debt of France would lose its AAA rating. When the French rumor went unfounded the market moved higher, but just temporarily. The averages stalled again after existing home sales data for March showed a decline versus an expected increase but gathered once more to move back into positive territory. As the day progressed and the European markets closed lower, the averages lost any momentum they'd found and fell back into negative ground. For the remainder of the day the market drifted in the red as investors prepared for the next round of corporate earnings reports... ECONOMIC EVENTS: In the U.S., more jobless claims applications were filed than forecast, with the figure hitting 386,000. Sales of previously owned homes in March unexpectedly fell 2.6% to a 4.48M annual rate from 4.6M in February. Forecasts had called for an increase to 4.61M. In Europe, Spain was able to sell more bonds than expected but at higher yields, leaving mixed impressions among investors... COMPANY NEWS: Bank of America (BAC) posted Q1 adjusted results that beat consensus, but shares declined 1.68% to $8.77. Among other Dow components, Verizon (VZ) and Travelers (TRV) also reported earnings that exceeded expectations and both saw their shares rise following the reports, with Verizon gaining 1.30% to $38.15 and Travellers advancing 3.75% to $61.70. Du Pont (DD) was the fourth Dow name to beat on earnings, but shares fell 1.24% to $52.61... Meanwhile, data analysis software company Splunk (SPLK) and luxury luggage and briefcase maker Tumi Holdings (TUMI) both surged after debuting their IPOs on the Nasdaq. Splunk shares priced at $17 and ended the day at $35.48, while Tumi priced at $18 and closed at $26.50… MAJOR MOVERS: Among the notable gainers were Human Genome Sciences (HGSI), up $7, or 97.63%, to $14.17, after saying it had turned down an unsolicited $13 per share, or approximately $2.6B, buyout proposal from GlaxoSmithKline (GSK), and eBay (EBAY), up $4.75, or 13.24%, to $40.62, as the company’s sales and profits beat analyst estimates, led by growth in its PayPal online payments business. Noteworthy losers included Gentex (GNTX), down $4.07, or 16.01%, to $21.35, after its top-line miss continued to reinforce investor fears over slowing growth, and Achillion (ACHN), down $1.20, or 12.63%, to $8.30, with the decline attributed by Wells Fargo to positive data for Gilead's (GILD) oral hepatitis C combination treatment… INDICES: The Dow lost $68.65, or 0.53%, to 12,964.10; the Nasdaq fell $23.89, or 0.79%, to 3,007.56; and the S&P 500 dropped $8.22, or 0.59%, to 1,376.92.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 >>
January 26, 2016
09:28 EDTDDCorning sees Q1 global economic headwinds to continue in Q1
Corning's (GLW) management said that volume in Q1 will reflect the weaker retail market. Management said that Q1 will be the weakest quarter in the fiscal year. The company sees glass market volumes to be down mid-to-high single digits. The company expects glass market volume growth to begin in Q2. The company sees prices to decline moderately sequentially in Q1. The company sees its optical communications segment up low-to-mid single digits. The company sees environmental sales down approximately 10% in Q1. Corning expects its special materials segment sales down mid teens. The company expects its life sciences sales up low-single digits. Dow Corning, Corning's joint venture with Dow Chemical (DD), equity earnings are expected to be approximately $45M in Q1. Corning sees core gross margin approximately 41% of sales in Q1. Guidance provided during Q4 earnings conference call.
09:05 EDTVZVerizon and Samsung launch network extender solution
Subscribe for More Information
08:29 EDTDDDuPont sees Agriculture Q1 sales down about 10%
In Agriculture, DuPont sees Q1 sales down about 10%, as local price gains are more than offset by lower crop protection and soybean volumes and currency; volumes will be more challenged in the first quarter due to the strong start in North America corn seed which benefited the fourth quarter of 2015. Sees Q1 segment operating earnings down low-twenty percent as local price gains are more than offset by lower volumes and currency. For full year, sees Agriculture sales down mid-single digits percent, as local price gains are more than offset by currency and lower crop protection and soybean volumes, with operating earnings about flat as local price gains and cost reductions and productivity are offset by currency and lower volumes; Sees FY Agriculture operating earnings up about 10% excluding currency.
08:26 EDTDDDuPont sees Q1 Performance Materials sales down high-single digits
Subscribe for More Information
08:24 EDTDDDuPont sees Q1 Safety & Protection sales down in the mid teens percent
For Safety & Protection, DuPont sees Q1 sales to decline in the mid teens percent vs. prior year, with operating earnings down high teens percent, reflecting cost reductions and continued productivity more than offset by the impact of lower sales and currency. Sees full year segment sales down by the low single digits percent, with volume growth offset by currency, and operating earnings up mid teens percent.
08:22 EDTDDDuPont sees Q1 Electronics & Communications sales down mid-teens percent
Subscribe for More Information
08:20 EDTDDDuPont sees Q1 Nutrition & Health sales down low-single digits
For Nutrition & Health segment, DuPont sees Q1 sales down low-single digits percent as volume growth is more than offset by the negative impact of currency. Sees Q1 operating earnings for the segment up low-single digits percent, as cost reductions and continued productivity more than offset the impact of currency. Sees Nutrition & Health segment full year sales down low-single digits percent, as volume growth is more than offset by the negative impact of currency. Sees full year operating earnings for the segment up high-teens percent, as cost reductions and continued productivity more than offset the impact of currency.
08:17 EDTDDDuPont sees Industrial Biosciences sales growth in low single digits in Q1
For Industrial Biosciences, DuPont sees modest volume growth in bioactives to be offset by unfavorable currency, resulting in sales growth in the low single digits percent vs. last year. Sees Q1 Industrial Biosciences operating earnings down by the mid single digit percent as cost reductions and continued productivity are expected to be more than offset by higher input costs and currency. For the full year in Industrial Biosciences, DuPont sees sales up low single digits on stronger volume and price, partly offset by currency. Sees segment operating earnings flat, with cost reductions offset by higher product costs and currency.
07:48 EDTDDDuPont repeats call for Dow Chemical merger to close in second half of 2016
Subscribe for More Information
07:22 EDTDDDuPont sees $1.3B cash used for normal dividends, $2B for repurchases in 2016
Among its expected uses of cash for 2016, DuPont lists $1.3B for normal dividends, $2B for its share repurchase program, to be use during 2nd half 2016 open trading windows, and capex spend estimated to be $1.1B. In 2016, DuPont assumes global GDP growth of 2%, industrial production growth of 2% and for the U.S. dollar to be stronger against most currencies. Guidance from slides for Q4 earnings call presentation.
06:22 EDTDDDuPont sees FY16 operating EPS $2.95-$3.10, consensus $3.15
Subscribe for More Information
06:22 EDTDDDuPont says actions for 2016 cost savings plan underway
Subscribe for More Information
06:21 EDTDDDuPont says cost reductions from operational redesign contributed 10c to Q4
Cost reductions from operational redesign contributed an incremental $0.10 per share to fourth-quarter operating earnings.
06:20 EDTDDDuPont reports Q4 operating EPS 27c, consensus 26c
Reports Q4 revenue $5.3B, consensus $5.39B.
January 25, 2016
16:00 EDTBACOptions Update; January 25, 2016
Subscribe for More Information
14:29 EDTDDNotable companies reporting before tomorrow's open
Subscribe for More Information
11:05 EDTGSKOncoMed price target lowered to $29 from $43 at Piper Jaffray
Subscribe for More Information
09:22 EDTSPLKSplunk poised to break out in 2016, says KeyBanc
Subscribe for More Information
09:04 EDTVZSprint doubles number of LTE Plus markets
Subscribe for More Information
06:53 EDTGSKGlaxo, Astra, J&J partner with universities in drug research fund, Reuters says
Subscribe for More Information
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use